SA
Sheikh Abdul Mozid
About Sheikh Abdul Mozid
Data last updated:
Sheikh Abdul Mozid is a Managing Director at Zoloncare Pharma Private Limited (since 2025) and Director at Ziomark Pharmaceuticals Private Limited (since 2021). The companies operate in Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 04 Feb 2025 | 2025 | Active | ||
| Director | 18 Nov 2021 | 2021 | Active |
Board colleagues of Sheikh Abdul Mozid
| Name | DIN | Company | Designation |
|---|---|---|---|
| Najma Ahmed | 10938384 | Zoloncare Pharma Private Limited | Director |
| Mahsin Ahmed | 09406035 | Ziomark Pharmaceuticals Private Limited | Director |
| Sheikh Faruk Abdullah | 09406037 | Ziomark Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sheikh Abdul Mozid
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sheikh Abdul Mozid
Sheikh Abdul Mozid currently holds 2 directorships: Zoloncare Pharma Private Limited (Managing Director, since 04 Feb 2025); Ziomark Pharmaceuticals Private Limited (Director, since 18 Nov 2021).
Sheikh Abdul Mozid was first appointed on 18 Nov 2021 as Director at Ziomark Pharmaceuticals Private Limited. The most recent appointment on record is 04 Feb 2025 at Zoloncare Pharma Private Limited.
The current boards of Sheikh Abdul Mozid's companies include Najma Ahmed (Zoloncare Pharma Private Limited), Mahsin Ahmed (Ziomark Pharmaceuticals Private Limited), Sheikh Faruk Abdullah (Ziomark Pharmaceuticals Private Limited).